Aaron Wealth Advisors LLC Grows Stock Holdings in CME Group Inc. (NASDAQ:CME)

Aaron Wealth Advisors LLC raised its holdings in CME Group Inc. (NASDAQ:CME) by 25.4% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 1,498 shares of the financial services provider’s stock after acquiring an additional 303 shares during the period. Aaron Wealth Advisors LLC’s holdings in CME Group were worth $331,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Oak Harvest Investment Services increased its stake in shares of CME Group by 66.5% in the first quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock worth $9,708,000 after buying an additional 18,017 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in CME Group by 21.2% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock valued at $9,477,000 after buying an additional 8,443 shares during the last quarter. Duality Advisers LP acquired a new position in shares of CME Group during the first quarter valued at $1,455,000. SG Americas Securities LLC grew its stake in shares of CME Group by 312.2% in the first quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock worth $12,222,000 after purchasing an additional 42,996 shares in the last quarter. Finally, Cetera Investment Advisers grew its position in CME Group by 429.1% in the 1st quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock valued at $10,231,000 after buying an additional 38,540 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity

In related news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Barclays lifted their target price on CME Group from $209.00 to $219.00 and gave the stock an “equal weight” rating in a report on Monday, October 7th. TD Cowen assumed coverage on CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target on the stock. Piper Sandler upped their price target on shares of CME Group from $225.00 to $240.00 and gave the company an “overweight” rating in a research report on Tuesday, October 8th. Keefe, Bruyette & Woods raised their price objective on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Finally, Redburn Atlantic lowered CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a research report on Tuesday, October 8th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $220.07.

CME Group Trading Up 0.5 %

Shares of NASDAQ:CME opened at $228.32 on Friday. The stock has a market cap of $82.21 billion, a PE ratio of 25.97, a P/E/G ratio of 7.76 and a beta of 0.55. The business has a 50 day moving average of $216.92 and a 200-day moving average of $208.34. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.12.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company’s revenue was up 12.7% compared to the same quarter last year. During the same period in the prior year, the company posted $2.30 EPS. As a group, equities research analysts forecast that CME Group Inc. will post 10.04 earnings per share for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.01%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.